Connect with us

Doral (quazepam)


Quazepam (or DORAL, DORMALIN®) is mainly prescribed to treat insomnia.

Status: ACTIVE

Class: Benzodiazepine

FDA Approval: 1985

Dosage Forms: 7.5 mg, 15 mg

Biological Half-life: 39 hours

Side Effects: Dizziness, daytime sleepiness, ataxia, hypokinesia, amnesia, poor concentration, lack of coordination

Precautions: Should NOT be taken during pregnancy

Routes of Administration: Oral

Pregnancy Category: X (US)

  www.fda.gov

Advertisement

© 2018 Mental Daily. All Rights Reserved.
Our content is for informational purposes and should not be used as medical or treatment recommendation.